Tag Archives: Hormone Replacement Therapy

Hormone Replacement Therapy Associated With Small Increased Risk of Developing Alzheimer’s Disease (BBC News / BMJ / NHS Digital)

Posted on March 8, 2019 by Dementia and Elderly Care News

Summary Research from Finland discovered a 9% to 17% increase in the risk of developing Alzheimer’s Disease in women taking hormone replacement therapy (HRT) for more than 10 years. The public has been advised not to be overly concerned, as absolute risk … Continue reading →

Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Pharmacological Treatments, Quick Insights, Statistics, Universal Interest | Tagged BBC Health News, Behind the Headlines, BMJ, BMJ Publishing Group Ltd, British Medical Journal (BMJ), Dementia Risk Factors, Dementia Risk Reduction and Prevention, Division of Family Medicine: Karolinska Institute, EPID Research Oy (Finland), Epidemiology, Epidemiology and Statistics, Estradiol, Finland, Folkhälsan Research Center (Finland), Helsinki University Hospital, Hormone Replacement Therapy, Hormone Therapy and Cognition, HRT, Jane and Aatos Erkko Foundation, Karolinska Institute, Karolinska Institute: Department of Neurobiology Care Sciences and Society, Medroxyprogesterone Acetate, Modifiable Risk Factors, National Institute for Health and Welfare (Finland), NHS Digital, NHS Digital (Formerly NHS Choices), Norethisterone Acetate, Obstetrics and Gynecology: University of Helsinki and Helsinki University Hospital, Oestrogen-Progestogen Therapy, Postmenopausal Hormone Therapy and Risk of Alzheimer’s Disease, Progestogens, Research Centre for Child Psychiatry: University of Turku, Risk Factors, Risk Factors and Preventive Interventions for Alzheimer Disease, Sweden, University of Helsinki and Helsinki University Hospital, University of Turku | Leave a comment

Early Menopause and Cognitive Decline (NHS Choices / BJOG)

Posted on May 11, 2014 by Dementia and Elderly Care News

Summary French research into the impact of a premature menopause (≤40 years) on cognitive function in later life indicates that premature surgical menopause and premature ovarian failure are associated with long-term negative effects on cognitive function. These effects are not … Continue reading →

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Statistics, Universal Interest | Tagged Australia, Behind the Headlines, Benton’s Visual Retention Test (BVRT), Bilateral Oophorectomy, BJOG, BJOG: International Journal of Obstetrics and Gynaecology, Bordeaux, Cancer and Disease Epigenetics: Murdoch Children's Research Institute [Melbourne], Centre Memoire Ressources et Recherche in Montpellier (France), CHRU Dijon: Centre Mémoire Ressources et Recherche, CHRU Montpellier: Centre Mémoire Ressources et Recherche, Cognitive Impairment, Department of Paediatrics: University of Melbourne, Dijon, Early Menopause, Early Menopause and Cognitive Decline, France, French Three-City Study, Hormone Replacement Therapy, Hormone Therapy (HT), HRT, Hysterectomy, Imperial College London, INSERM, Isaacs’ Set Test, MCI: Mild Cognitive Impairment, Mental Decline, Mental Speed and Agility, Mild Cognitive Impairment (MCI), Montpellier, Montpellier and Bordeaux Universities, Murdoch Children's Research Institute: Australia, Neuropsychiatry: Epidemiological and Clinical Research (Montpellier), Non-Surgical Loss of Ovarian Function, Ovarian Failure, Ovariectomy, Postmenopausal Hormone Therapy, Premature Bilateral Ovariectomy, Premature Ovarian Failure, Trail Making Tests, Université Montpellier, Verbal Fluency, Visual Memory | Leave a comment

Recent Systematic Reviews and Meta-Analyses on Epidemiological Studies, Risk Factors and Prevention

Posted on January 19, 2014 by Dementia and Elderly Care News

Some of the following articles are available freely. Access to the full-text of the other articles requires a suitable Athens password, a journal subscription or payment. The Bibliographic Citations Bliwise, DL. (2013). Alzheimer’s Disease, sleep apnea, and positive pressure therapy. … Continue reading →

Posted in For Doctors (mostly), For Researchers (mostly), International, Parkinson's Disease, Systematic Reviews | Tagged Alzheimer’s Disease: Prevalence, Blood Pressure, Chronic Traumatic Encephalopathy, Conversion Rates, Conversion to Dementia, Dementia with Lewy Bodies, DLB: Dementia with Lewy Bodies, Epidemiology, Epidemiology and Statistics, HIV-Associated Neurocognitive Disorders, Hormone Replacement Therapy, Hormone Therapy (HT), Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorder (HAND), Hypertension, Lewy Body Dementia, Mediterranean Diet, Modifiable Risk Factors, Positive Pressure Therapy, Prevalence of Dementia, Prevention, Prevention Programmes, Risk Factors, Sleep Apnea, Social Epidemiology, Statins, Sub-Saharan Africa, Use of Statins, Vitamin B12 | Leave a comment

NICE Eyes on Evidence: Cumulative Index 2013 (NICE Evidence)

Posted on September 12, 2013 by Dementia and Elderly Care News

Summary The NICE Evidence‘s Eyes on Evidence service covers significant new evidence across a range of topics. Here is an alphabetical list of the items, which have appeared so far this year, of broad interest to readers of this information … Continue reading →

Hormone Replacement Therapy to Slow Dementia Onset? (NHS Choices / PLoS One)

Posted on February 16, 2013 by Dementia and Elderly Care News

Summary This NHS Choices critical appraisal examines press coverage of recent research which investigated the relationship between the genetic variant APOE-e4 (which increases the risk of developing Alzheimer’s Disease), hormone replacement therapy (HRT) and telomere length (an indicator of cell … Continue reading →

Posted in For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Universal Interest | Tagged Alzheimer's Gene (APOE4 Gene), ApoE and Genetics of Alzheimer's Disease, ApoE e4 Allele, APOE4 Gene, Apolipoprotein E (APOE) e4 Allele, Apolipoprotein E (APOE) Gene, Behind the Headlines, Cell Ageing, Cell Aging, Common Genetic Risk Factor Links Alzheimer’s Disease and Type 2 Diabetes (SorCS1), Female APOE-ε4 Carriers, Genetics of Alzheimer's Disease, Hormone Replacement Therapy, HRT, PLoS One, Post-Menopausal Women, Telomere Length, Telomeres | Leave a comment

Hormone Replacement Therapy and Risk of Alzheimer’s Disease (Neurology)

Posted on November 3, 2012 by Dementia and Elderly Care News

Summary A study by US researchers, and published in the Neurology journal, has linked hormone replacement therapy (HRT) in women to both an increased and a decreased risk of Alzheimer’s Disease, depending on the type of hormones used and the timing … Continue reading →

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Pharmacological Treatments, Proposed for Next Newsletter, Quick Insights, Universal Interest | Tagged Cache County Research (US), Cache County Study, Center for Epidemiologic Studies: Utah State University, Department of Health Sciences Research: Division of Epidemiology; Mayo Clinic, Department of Mental Health: Johns Hopkins Bloomberg School of Public Health, Department of Psychiatry and Behavioral Sciences: Duke University School of Medicine, Department of Psychiatry: McGill University Faculty of Medicine, Department of Public Health (USA), Departments of Health Research and Policy (Epidemiology) and Neurology and Neurological Sciences: Stanford University, Division of Research: Kaiser Permanente Northern California, Estrogens and Alzheimer’s Disease Risk, Hormone Replacement Therapy, Hormone Therapy (HT), HRT, HRT: Window of Opportunity, Kaiser Permanente, Menopause, Neurology, Oestrogens and Alzheimer’s Disease Risk, Timing of HRT, University of Memphis, Weill Cornell Medical College: New York | Leave a comment

Risk Factors and Aetiology (NHS Evidence, Alzheimer’s Disease and Dementia Annual Evidence Update 2008)

Posted on December 1, 2010 by Dementia and Elderly Care News

Abstract The 2008 Annual Evidence Update (AEU) , produced by NHS Evidence, gives an overview of the most important evidence published during the period Spring 2007 – Summer 2008. This section of the AEU is aimed at clinicians in primary care … Continue reading →

Posted in Acute Hospitals, Community Care, For Doctors (mostly), For Researchers (mostly), National, NHS Evidence, Systematic Reviews, Universal Interest | Tagged Aetiology, Alzheimer's Disease and Dementia, Annual Evidence Update 2008, ApoE and Genetics of Alzheimer's Disease, Genetics of Alzheimer's Disease, Hormone Replacement Therapy, HRT, MCI, Mild Cognitive Impairment, NHS Evidence, Obesity, Occupational Exposure, Risk Factors, Smoking, Vascular and Lifestyle Factors | Leave a comment

Tag Archives: Hormone Replacement Therapy

Hormone Replacement Therapy Associated With Small Increased Risk of Developing Alzheimer’s Disease (BBC News / BMJ / NHS Digital)

Early Menopause and Cognitive Decline (NHS Choices / BJOG)

Hormone Replacement Therapy to Slow Dementia Onset? (NHS Choices / PLoS One)

Risk Factors and Aetiology (NHS Evidence, Alzheimer’s Disease and Dementia Annual Evidence Update 2008)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites